-

Thermo Fisher Scientific Launches New ENERGY STAR certified TSX Universal Series ULT Freezers to Deliver Tighter Temperature Control and Faster Recovery Times

Enhanced performance and 33% energy savings support quality and sustainability goals in the laboratory

CARLSBAD, Calif.--(BUSINESS WIRE)--Building on 80 years of expertise engineering cold storage lab equipment, Thermo Fisher Scientific today introduces its newest line of high performance, ultra-low temperature (ULT) freezers. With enhancements to performance, user experience and energy efficiency, the Thermo Scientific™ TSX™ Universal Series ULT Freezers seamlessly adapt to scientists’ workflows across a variety of lab settings, marking a new era in performance, reliability, and sustainability.

Laboratories require reliable and effective cold storage solutions for their samples, often at a very specific temperature range, to advance critical research, adequately store samples or accelerate the development of new therapies. With Universal V-Drive technology, tighter control, faster recovery times, universal voltage, and an expanded setpoint range, the TSX Universal Series seamlessly adapts to diverse workflows, from high-use academic labs to longer-term storage facilities. Delivering both industry leading performance and energy efficiency, the TSX Universal Series allows labs to meet their sustainability goals without sacrificing performance.

“With the advancement of new therapeutic technologies and tighter regulatory focus on the pharmaceutical cold chain, there’s a clear need for enhanced and manageable cold storage solutions across a variety of settings,” said Carlos Sevilla, vice president and general manager, Controlled Temperature Technologies at Thermo Fisher Scientific. “Following extensive research and development, we’re proud to launch the next generation TSX Universal Series of ULTs, enabling high-use academic labs, GMP labs and long-term storage facilities to use the same unit throughout diverse workflows while supporting their own sustainability goals.”

TSX Universal Series ULT freezers undergo rigorous long-term reliability testing, having undergone +5400 combined days of continuous reliability testing in the field and laboratory environments to help ensure each unit meets Thermo Fisher Scientific's stringent quality standards. ENERGY STAR® certified and produced in a Zero-Waste to Landfill certified facility, the TSX Universal Series ULT freezers are designed with sustainability in mind and provide easy-to-use information about the products' environmental impact through the ACT label program, run by the non-profit organization My Green Lab.

For the first time, the TSX Series ULT platform offers medical device units, to store and preserve blood and blood products at freezing temperatures between -40°C to -86°C for users operating in GMP or qualified environments.* By obtaining ISO Class 5.5 cleanroom designation for TSX Universal Series ULT freezers, cell and gene therapy customers can have confidence in the cleanliness and control of their storage environments. Additionally, customers can benefit from an industry-leading warranty and global service support through Unity Lab Services.

To learn more about the new TSX Universal Series ULTs, please visit www.thermofisher.com/TSXUniversalULT

*Registered as a medical device in the US only. Verification of medical devices in the U.S. can be found on: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfrl/rl.cfm

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Contacts

Media Contact Information:
Shannon Stoneking
Phone: 484-748-1279
E-mail: shannon.stoneking@thermofisher.com

Jessika Parry
Phone: 419-266-4016
Email: jparry@greenoughagency.com

Thermo Fisher

NYSE:TMO
Details
Headquarters: Waltham, Massachusetts
CEO: Marc N. Casper
Employees: 100,000
Organization: PUB
Revenues: $40 Billion (2021)

Release Versions

Contacts

Media Contact Information:
Shannon Stoneking
Phone: 484-748-1279
E-mail: shannon.stoneking@thermofisher.com

Jessika Parry
Phone: 419-266-4016
Email: jparry@greenoughagency.com

More News From Thermo Fisher

Nalgene Outdoor Surpasses $1.2 Million in Water Access Impact, Expands Commitment on World Water Day

ROCHESTER, N.Y.--(BUSINESS WIRE)--In America, where refillable water bottles are common, more than 2 million people still lack clean running water at home. To help close that gap, Nalgene Outdoor, maker of reusable water bottles, is expanding its commitment to domestic water access after surpassing $1.2 million in funding and in-kind support since launching the Nalgene Water Fund in 2019. The Fund is committing $50,000 to DigDeep, a national nonprofit advancing equitable water access, matching...

Thermo Fisher Scientific Opens Bay Area Cryo-EM Drug Discovery Center to Accelerate Breakthrough Therapies

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today announced the opening of its Cryo-Electron Microscopy (cryo-EM) Drug Discovery Center (CDDC) in South San Francisco. The new center provides pharmaceutical and biotechnology innovators with immersive, hands-on access to advanced cryo-EM technologies designed to accelerate structural insights and the development of life-saving therapies. Accelerating Drug Discovery with Cryo-EM The...

Thermo Fisher Scientific Launches New Color-Based (Chromogenic) Culture Media to Help Detect Candida Infections Faster*, Including Drug-Resistant Candida auris

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today announced the launch of Thermo Scientific™ Brilliance™ Candida 2 Agar and Spectra™ Candida Agar**, new color-based (chromogenic) culture media to help laboratories quickly detect and differentiate clinically important Candida species — including Candida auris, a growing global antimicrobial resistance (AMR) threat1. Invasive fungal infections are an increasing challenge for healthcare systems w...
Back to Newsroom